When someone tests positive for HLA-B27, experiences chronic back pain, but has normal imaging results, it can create confusion and frustration. One possible explanation is a condition known as non-radiographic spondyloarthropathy—a lesser-known but real and treatable form of inflammatory arthritis.

According to Dr. Siddharth Tambar of Chicago Arthritis and Regenerative Medicine, this scenario is not uncommon in clinical practice. Here’s what patients and healthcare providers need to know.

What Is HLA-B27?

HLA-B27 is a genetic marker present in about 6–8% of the general population. While its presence alone doesn’t confirm disease, it significantly increases the risk for autoimmune and inflammatory disorders such as ankylosing spondylitis (AS).

How Ankylosing Spondylitis Differs from Mechanical Back Pain

Ankylosing spondylitis is a chronic inflammatory condition primarily affecting the spine and sacroiliac (SI) joints. Unlike mechanical back pain—which typically worsens with movement and improves with rest—inflammatory back pain is often worse in the morning or after rest and improves with activity.

Common symptoms include:

• Persistent low back pain

• Morning stiffness lasting over an hour

• Fatigue and pain that ease with movement

Understanding Non-Radiographic Spondyloarthropathy

Non-radiographic spondyloarthropathy shares many of the same symptoms as ankylosing spondylitis but lacks the visible changes on X-ray or MRI that define AS. Patients may still experience significant pain, stiffness, and systemic inflammation, even if imaging appears normal.

Diagnosis may be considered when a patient is HLA-B27 positive and presents with at least two additional features such as:

• Inflammatory back pain

• Peripheral joint or tendon inflammation

• Uveitis (eye inflammation)

• Psoriasis or inflammatory bowel disease

• Elevated inflammatory markers (CRP or SED rate)

• Positive response to anti-inflammatory medications

• Family history of spondyloarthritis

Diagnostic Process

Accurate diagnosis requires a detailed clinical evaluation, including:

• Thorough medical history and physical exam

• MRI of the SI joints to detect early inflammation

• Blood tests for inflammatory markers

• Musculoskeletal ultrasound if peripheral symptoms are present

• Ruling out other causes such as degenerative arthritis or joint instability

Treatment Approach

Treatment for non-radiographic spondyloarthropathy is based on symptom severity and risk of progression, not just imaging results. A stepwise plan often includes:

1. Conservative management

   • Regular exercise and physical therapy

   • Anti-inflammatory diet and supplements (e.g., omega-3s, curcumin)

   • Over-the-counter anti-inflammatory medications

2. Medical therapies

   • Disease-modifying drugs like sulfasalazine

   • Biologic medications such as TNF or IL-17 inhibitors for more severe or persistent cases

Dr. Tambar emphasizes that early intervention and personalized treatment are essential. Even in the absence of radiographic evidence, untreated inflammation can lead to progression over time.

Final Thoughts

Being HLA-B27 positive with back pain but no imaging findings doesn’t rule out an inflammatory condition. Non-radiographic spondyloarthropathy is a legitimate diagnosis that requires clinical expertise to identify and manage. Early treatment based on symptoms and risk factors—not just lab or imaging results—can lead to better outcomes and a better quality of life.

---

Ankylosing Spondylitis vs. Mechanical Back Pain: Key Differences & When to Seek Help

Can We Really Treat Chronic Back Pain? Here’s What Works.

Inflammatory vs. Degenerative Back Pain: Key Differences You Need to Know